CIK 0001720893
- Non-accelerated filer
- Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821386754
- Phone
- +1 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 1,693 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 65 shares (option exercise)
- 4 Exercise or conversion Rodriguez Javier acquired 65 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 65 shares (option exercise)
- 4 Exercise or conversion CEO and President acquired 379 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,693 shares (option exercise)
- 4 Exercise or conversion Director acquired 27,089 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 27,089 shares (option exercise)
- 4 Planned sale O'Neill Vincent sold 165 shares at $0.35 ($58)
- 4 Planned sale CEO and President sold 3,117 shares at an average $0.36 ($1,131)
- 4 Planned sale Chief Financial Officer sold 577 shares at an average $0.36 ($207)
- 4 Planned sale Rodriguez Javier sold 430 shares at an average $0.36 ($153)
- 4 Planned sale Chief Scientific Officer sold 430 shares at an average $0.35 ($152)
Page 4 of 14 · 276 filings